- Home
- AMBP vs ARWR Comparison
AMBP vs ARWR Comparison
Compare AMBP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- ARWR
- Stock Information
- Founded
- AMBP 2021
- ARWR 2003
- Country
- AMBP Luxembourg
- ARWR United States
- Employees
- AMBP N/A
- ARWR N/A
- Industry
- AMBP Containers/Packaging
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- AMBP Industrials
- ARWR Health Care
- Exchange
- AMBP Nasdaq
- ARWR Nasdaq
- Market Cap
- AMBP 2.2B
- ARWR 2.5B
- IPO Year
- AMBP N/A
- ARWR 1993
- Fundamental
- Price
- AMBP $3.61
- ARWR $28.67
- Analyst Decision
- AMBP Buy
- ARWR Strong Buy
- Analyst Count
- AMBP 4
- ARWR 8
- Target Price
- AMBP $4.40
- ARWR $47.75
- AVG Volume (30 Days)
- AMBP 798.8K
- ARWR 2.8M
- Earning Date
- AMBP 10-23-2025
- ARWR 08-07-2025
- Dividend Yield
- AMBP 11.10%
- ARWR N/A
- EPS Growth
- AMBP N/A
- ARWR N/A
- EPS
- AMBP N/A
- ARWR N/A
- Revenue
- AMBP $5,231,000,000.00
- ARWR $572,976,000.00
- Revenue This Year
- AMBP $11.74
- ARWR $22,306.37
- Revenue Next Year
- AMBP $2.02
- ARWR N/A
- P/E Ratio
- AMBP N/A
- ARWR N/A
- Revenue Growth
- AMBP 8.39
- ARWR 2816.20
- 52 Week Low
- AMBP $2.50
- ARWR $9.57
- 52 Week High
- AMBP $4.78
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- AMBP 42.13
- ARWR 70.36
- Support Level
- AMBP $3.43
- ARWR $27.10
- Resistance Level
- AMBP $3.64
- ARWR $31.13
- Average True Range (ATR)
- AMBP 0.09
- ARWR 1.51
- MACD
- AMBP 0.02
- ARWR 0.32
- Stochastic Oscillator
- AMBP 61.02
- ARWR 76.66
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.